The New Margin Wars in Oncology Less Is More…Until It Isn’t Abstract The concept of the surgical margin has long stood at the center of oncologic surgery, traditionally guided by the principle that wider excision confers superior local control and improved survival. Historically, radical
Tag: oncology
Why Biomarker-Driven Treatment Fails: The Hidden Role of Histology
Why Biomarker-Driven Treatment Fails The Hidden Role of Histology Introduction Biomarker-driven treatment has fundamentally transformed oncology, ushering in an era of precision medicine in which therapeutic decisions are increasingly guided by the molecular characteristics of tumors rather than their anatomical origin alone. A
Skyrocketing Cancer Drug Prices: Can Oncologists Influence Policy?
Skyrocketing Cancer Drug Prices Can Oncologists Influence Policy Abstract The rapid escalation of cancer drug prices has emerged as a major challenge in contemporary oncology practice, with many newly approved therapies carrying annual costs that exceed one hundred thousand dollars per patient. This
Radiomics in Cancer Care: Breaking Down the Evidence Behind the Buzz
Radiomics in Cancer Care: Breaking Down the Evidence Behind the Buzz Introduction Radiomics represents a rapidly advancing field within oncology that extracts high-dimensional quantitative data from medical imaging, offering the potential to transform cancer diagnosis, prognosis, and treatment strategies. This emerging discipline is built
PE Protocol: Expert Guide to Managing Incidental Findings on CT Scans
PE Protocol: Expert Guide to Managing Incidental Findings on CT Scans Introduction The implementation of proper pulmonary embolism (PE) protocols is a critical component of modern clinical practice. Pulmonary embolism remains a potentially life-threatening condition, occurring in approximately 5% of patients undergoing computed
BTK Inhibitors in CLL: New Clinical Evidence Reshapes First-Line Treatment
BTK Inhibitors in CLL: New Clinical Evidence Reshapes First-Line Treatment Please like and subscribe if you enjoyed this video :-) Introduction The treatment landscape for chronic lymphocytic leukemia (CLL), the most common leukemia in Western countries, has undergone a major shift with the advent of Bruton’s tyrosine kinase
Monoclonal Antibodies in Relapsed Multiple Myeloma: The Era of Bispecifics and Beyond
Monoclonal Antibodies in Relapsed Multiple Myeloma: The Era of Bispecifics and Beyond Check back later for a possible video summary. Videos are created for most articles. Abstract This paper provides an in-depth review of monoclonal antibody (mAb) therapies in the treatment of relapsed multiple myeloma (MM), with a particular focus on bispecific antibodies
Cancer Vaccines for Treatment: Breaking Through Scientific Barriers in 2025
Breaking Barriers: CAR-T Therapy Shows Promise Against Solid Tumors
Liquid Biopsies – The Future of Early Cancer Detection
